Aceto Corp (ACETQ)

INDUSTRIALS: DISTRIBUTORS
SIC: WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

4 TRI HARBOR COURT PORT WASHINGTON, NY 11050

Aceto is engaged in the marketing, sales and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and chemicals. Co.'s business is organized along product lines into three segments: Human Health, which includes finished dosage form generic drugs and nutraceutical products; Pharmaceutical Ingredients, which consist of active pharmaceutical ingredients and pharmaceutical intermediates; and Performance Chemicals, which provide a range of chemicals for plastics, surface coatings, textiles, fuels and lubricants, and agricultural protection products.

View SEC Filings from ACETQ instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 1 1 0.0% 1 (0.07%) 1 (0.06%) 0.0%
13F shares: 658.63 Thousand 658.63 Thousand 0.0% 658.63 Thousand 658.63 Thousand 0.0%
% Ownership
New Positions: 1 1
Increased Positions
Closed Positions
Reduced Positions
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ACETQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACETQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EILENDER ALBERT L

  • Director
0 2019-10-01 0

BRITTON WILLIAM N

  • Director
0 2019-10-01 0

GIORDANO NATASHA

  • Director
0 2019-10-01 0

ROGERS STEVEN PRESIDENT

  • Officer
  • Director
1 2019-10-01 0

LEVIN ALAN G

  • Director
0 2019-10-01 0

YAROSH DANIEL B.

  • Director
0 2019-10-01 0

KENNALLY WILLIAM C. III

  • Director
0 2019-10-01 0

DEBENEDITTIS FRANK SR. VICE PRESIDENT

  • Officer
44,467 2019-02-26 0

SCALLY FRANCES P SVP, CHIEF ACCOUNTING OFFICER

  • Officer
16,917 2018-12-26 0

ALAIMO CHARLES JOHN SENIOR VICE PRESIDENT

  • Officer
21,587 2018-10-04 0

KACZMAREK WALTER J III CHIEF OPERATING OFFICER

  • Officer
56,782 2018-09-07 0

BORKOWSKI EDWARD CHIEF FINANCIAL OFFICER

  • Officer
60,000 2018-02-21 0

ROTH DOUGLAS A SR. VICE PRESIDENT & CFO

  • Officer
105,694 2017-09-05 0

GUCCIONE SALVATORE J SR PRESIDENT AND CEO

  • Officer
  • Director
245,051 2017-09-05 0

KIPPLEY TERRY SR. VICE PRESIDENT

  • Officer
20,337 2016-12-16 0

BARTONE RAYMOND SENIOR VICE PRESIDENT

  • Officer
33,452 2016-12-09 0

SHACKLEY NICOLAS I SENIOR VICE PRESIDENT

  • Officer
31,476 2016-12-08 0

NOETZLI HANS C

  • Director
83,039 2016-12-01 0

SRINIVASAN SATISH PRESIDENT & COO - RISING PHARM

  • Officer
20,434 2016-11-29 0

RESTREPO CARLOS SR. VICE PRESIDENT

  • Officer
23,320 2016-09-01 0

WEAVING ROGER JR SENIOR VICE PRESIDENT

  • Officer
51,296 2014-02-14 0

RANDALL RICHARD P

  • Director
31,090 2013-12-05 0

WIESEN ROBERT A

  • Director
22,867 2013-08-08 0

VAN EIS JAN MANAGING DIRECTOR

  • Officer
14,021 2013-07-25 0

SAINT-CLAIR GUILLAUME V.P. PHARMA INTERMEDIATE

  • Officer
11,255 2013-07-25 0

HIPPEL LUKAS VON MANAGING DIRECTOR

  • Officer
11,000 2013-07-25 0

GOLD RONALD PRESIDENT & COO - RISING PHARM

  • Officer
730,500 2013-05-24 0

ROSEN DAVID B. SR. V.P. - RISING PHARMA

  • Officer
166,500 2013-05-14 0

FEINMAN MICHAEL W PRESIDENT, ACETO AGRICULTURAL

  • Officer
29,005 2011-12-12 0

BENDER ULF MANAGING DIRECTOR

  • Officer
0 2011-12-06 0

MIATA VINCENT G PRESIDENT & COO

  • Officer
60,540 2011-08-03 0

SHAPIRO BRIAN VICE PRESIDENT - RISING PHARMA

  • Officer
15,997 2011-08-03 0

FISCHER STANLEY H

  • Director
19,731 2009-12-10 0

SCHWARTZ LEONARD S CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
627,078 2009-11-18 0

STEINBERG TERRY VICE PRESIDENT

  • Officer
25,475 2009-06-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments